Nathan Denlinger

4PUBLICATIONS
63CO-AUTHORS
Molecular targetsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 14, 2026
Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22.

|Apr 09, 2025
Bridging radiotherapy before chimeric antigen receptor T cells for B-cell lymphomas: an ILROG multicenter study.

Nikhil Yegya-Raman, John P Plastaras, Christopher M Wright

|Oct 22, 2024
Siltuximab for chimeric antigen receptor T-cell therapy-related CRS and ICANS: a multicenter retrospective analysis.

Amneet Bajwa, Qiuhong Zhao, Marcus Geer

|Apr 12, 2024
Postinfusion PD-1+ CD8+ CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma.

Nathan Denlinger, No-Joon Song, Xiaoli Zhang

Pageof 1

Frequent Collaborators

3 joint publications

Evandro D Bezerra

3 joint publications

Narendranath Epperla

3 joint publications

Timothy Voorhees

3 joint publications

Marcos de Lima